55,667 results on '"ENDOMETRIAL cancer"'
Search Results
102. Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium (B-FiERCE)
103. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
104. Multiorgan Metabolic Imaging Response Assessment of Abemaciclib (MiMe-A)
105. Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer (EndoSLN)
106. Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator
107. Atezolizumab Trial in Endometrial Cancer - AtTEnd (AtTEnd)
108. FitEx for Endometrial Cancer Survivors: Initial Efficacy
109. ZW25 in Women With Endometrial Cancers
110. A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
111. Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer
112. Myeloprotection With Trilaciclib in Pan-cancer Population
113. Vaginal Fluid Collection for Detection of Endometrial Cancer
114. Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
115. Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study.
116. Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
117. Integrated Cancer Repository for Cancer Research (iCaRe2)
118. Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study (GynCAT)
119. Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer. (Romantic)
120. Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis
121. Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications (POTENTIATE)
122. Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
123. First in Human Study of IMGN151 in Recurrent Endometrial Cancer and Recurrent, High-grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers
124. Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
125. Avera Cancer Sequencing and Analytics Protocol (ASAP) (ASAP)
126. From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy
127. DOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer (DORA)
128. Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) (TTBF)
129. Non-Invasive Diagnosis of Endometrial Cancer (NIECE)
130. Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors
131. Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
132. Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health (AMPLIFY)
133. Detection of Endometrial Cancer Through Risk Modelling (DETECTR)
134. Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil (MADONNA)
135. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)
136. A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
137. ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
138. Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients (VUBAR)
139. Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium (Clovis-001)
140. Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
141. Bariatric Education for Women With Obesity and Endometrial Cancer (SCC-BAREDU)
142. Improving Care After Inherited Cancer Testing (IMPACT)
143. COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
144. Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
145. A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors
146. Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
147. A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer
148. Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
149. HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
150. A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.